Explore more publications!

Laos Business Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Laos Business Times.

Press releases published on February 2, 2026

Palomar Holdings, Inc. Completes Acquisition of The Gray Casualty & Surety Company and Closes $450 Million Credit Facility
Fabrinet Announces Second Quarter Fiscal Year 2026 Financial Results
Muzero Acquisition Corp Announces Closing of $201,250,000 Initial Public Offering, Including Full Exercise of Underwriters' Over-Allotment Option
XAI Madison Equity Premium Income Fund Declares its Monthly Distribution of $0.060 per Share
XAI Octagon Floating Rate & Alternative Income Trust Declares its Monthly Common Shares Distribution of $0.060 per Share
Newbridge Acquisition Limited Announces Closing of $57.5 Million Initial Public Offering
Diversified Royalty Corp. Announces $50 Million Bought Deal Public Offering of 5.75% Convertible Unsecured Subordinated Debentures
Sezzle to Announce Fourth Quarter 2025 Results and Participate in Upcoming Investor Events
MediaAlpha To Report Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026
EverQuote to Announce Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026
United States Lime & Minerals Reports Fourth Quarter and Full Year 2025 Results and Declares Regular Quarterly Cash Dividend
NXP Semiconductors Reports Fourth Quarter and Full-Year 2025 Results
AtlasClear Holdings Launches “Clearing the View,” an Ongoing Investor Communications Series
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
CarGurus To Report Fourth Quarter and Full-Year 2025 Financial Results
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Arteris to Announce Financial Results for the Fourth Quarter and Year End 2025 on Thursday, February 12, 2026
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions